Strategic Wealth Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$134K Sell
458
-247
-35% -$81.2K 0.01% 355
2025
Q4
$247K Sell
705
-1,703
-71% -$575K 0.02% 292
2025
Q3
$778K Sell
2,408
-1,811
-43% -$563K 0.06% 181
2025
Q2
$1.64M Buy
+4,219
New +$1.7M 0.13% 116
2024
Q4
$1.64M Sell
4,192
-708
-14% -$296K 0.14% 116
2024
Q3
$2.55M Sell
4,900
-1,924
-28% -$1.03M 0.24% 92
2024
Q2
$3.7M Sell
6,824
-16
-0.2% -$8.46K 0.39% 79
2024
Q1
$3.55M Buy
6,840
+172
+3% +$85.5K 0.39% 82
2023
Q4
$3.14M Sell
6,668
-236
-3% -$109K 0.39% 81
2023
Q3
$3.01M Sell
6,904
-87
-1% -$39.5K 0.4% 74
2023
Q2
$3.11M Buy
6,991
+6,367
+1,020% +$2.94M 0.4% 76
2023
Q1
$287K Buy
+624
New +$297K 0.04% 219
2020
Q2
Sell
-810
Closed -$245K 140
2020
Q1
$245K Buy
+810
New +$221K 0.13% 124
2019
Q4
Sell
-1,359
Closed -$110K 233
2019
Q3
$110K Sell
1,359
-3,307
-71% -$906K 0.56% 51
2019
Q2
$1.32M Sell
4,666
-482
-9% -$132K 0.64% 44
2019
Q1
$1.48M Buy
5,148
+910
+21% +$263K 0.68% 41
2018
Q4
$1.1M Sell
4,238
-26
-0.6% -$7.15K 0.55% 50
2018
Q3
$1.17M Buy
4,264
+513
+14% +$133K 0.62% 50
2018
Q2
$893K Buy
+3,751
New +$869K 0.52% 63

Other funds holding ELV

Strategic Wealth Partners's ELV Position: Q1 2026 in Review

Strategic Wealth Partners reduced its Elevance Health (ELV) stake by 35% in Q1 2026, selling an estimated $81.2K and leaving 458 shares worth $134K. The position accounts for 0.01% of the portfolio, ranked #355.

Strategic Wealth Partners first reported a position in ELV in Q2 2018 and has held it in 19 quarters since. The position peaked at $3.7M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Strategic Wealth Partners held 458 shares of Elevance Health worth $134K as of Q1 2026.
  • Strategic Wealth Partners sold 247 Elevance Health shares in Q1 2026, an estimated $81.2K.
  • Elevance Health made up 0.01% of Strategic Wealth Partners's portfolio in Q1 2026, its #355 holding.
  • Strategic Wealth Partners first reported a position in Elevance Health in Q2 2018 and has held it in 19 quarters since.
  • Strategic Wealth Partners's Elevance Health position peaked at $3.7M in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Strategic Wealth Partners's 13F filing for Q1 2026, filed 12 May 2026.